Advertisement

Topics

Stemedica Posts Alzheimer’s Stem Cell Data

10:24 EDT 20 Aug 2014 | Drug Discovery Development

Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease.

Original Article: Stemedica Posts Alzheimer’s Stem Cell Data

NEXT ARTICLE

More From BioPortfolio on "Stemedica Posts Alzheimer’s Stem Cell Data"

Quick Search
Advertisement
 

Relevant Topic

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...